Literature DB >> 1391530

Enhancement of fractionated radiation therapy by an experimental concentrated perflubron emulsion (Oxygent) in the Lewis lung carcinoma.

B A Teicher1, T S Herman, K Menon.   

Abstract

The concentrated Perflubron emulsion, Oxygent, in combination with breathing a 95% oxygen atmosphere, significantly enhanced the response of the murine Lewis lung carcinoma to fractionated radiation therapy. Administration of 4 to 12 g PFC/kg was most effective if administered prior to each x-ray fraction, however, alternated day and even once weekly administration of 8 or 12 PFC/kg and 95% oxygen breathing with each x-ray fraction resulted in significant improvements in tumor growth delay.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1391530     DOI: 10.3109/10731199209119737

Source DB:  PubMed          Journal:  Biomater Artif Cells Immobilization Biotechnol        ISSN: 1055-7172


  4 in total

Review 1.  Imaging tumor hypoxia to advance radiation oncology.

Authors:  Chen-Ting Lee; Mary-Keara Boss; Mark W Dewhirst
Journal:  Antioxid Redox Signal       Date:  2014-03-24       Impact factor: 8.401

2.  Potentiation of cytotoxic therapies by TNP-470 and minocycline in mice bearing EMT-6 mammary carcinoma.

Authors:  B A Teicher; S A Holden; N P Dupuis; Y Kakeji; M Ikebe; Y Emi; D Goff
Journal:  Breast Cancer Res Treat       Date:  1995       Impact factor: 4.872

3.  Perfluorocarbon nanodroplets can reoxygenate hypoxic tumors in vivo without carbogen breathing.

Authors:  Yun Xiang; Nicholas Bernards; Bryan Hoang; Jinzi Zheng; Naomi Matsuura
Journal:  Nanotheranostics       Date:  2019-03-11

Review 4.  Nanomedicines: A Potential Treatment for Blood Disorder Diseases.

Authors:  Nan Zhang; Ming-Yuan Wei; Qiang Ma
Journal:  Front Bioeng Biotechnol       Date:  2019-11-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.